Back to mobile site

More on KOD

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)
- Holders

Upcoming Events

- Earnings (11/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Kodiak Sciences Inc. (NQ:KOD)
Delayed: 32.42 -0.29 (0.89%)
Prev. Close $32.71  
Open$33.04 
52 Wk High$ 
52 Wk Low$ 
Day High$33.34 
Day Low$32.00 
P/E N/A  
EPS$ 
Volume665,944 

Friends, Peers and Foes (?): 6XY, F, ORGO, PLNT PYPL (more...)

Sep 17, 2026 06:52 AM H.C. Wainwright Reiterates Buy Rating on Kodiak Sciences Inc. (KOD)
Aug 17, 2026 06:43 AM H.C. Wainwright Reiterates Buy Rating on Kodiak Sciences Inc. (KOD)
Aug 14, 2026 10:39 AM Form SCHEDULE 13G Kodiak Sciences Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Aug 13, 2026 04:39 PM Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
Aug 13, 2026 04:18 PM Form 10-Q Kodiak Sciences Inc. For: Jun 30
Aug 13, 2026 04:00 PM Form 8-K Kodiak Sciences Inc. For: Aug 13
Aug 13, 2026 04:00 PM Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2026 Financial Results
Aug 10, 2026 04:44 PM Kodiak Sciences enrolls first patients in Phase 3 DME trial
Aug 10, 2026 04:43 PM Kodiak Sciences Announces First Patients Enrolled in Global Phase 3 ALTO trial of KSI-501 in Patients with Diabetic Macular Edema
Aug 6, 2026 07:00 AM Kodiak Sciences completes enrollment in Phase 3 PEAK trial cohort
View All Articles

Entities mentioned with KOD

View All Entities